Phototherapy, photodynamic therapy and photophoresis in the treatment of connective-tissue diseases: A review

British Journal of Dermatology

Volumn 173, Issue 1, 2015, Pages 19-30

  Gordon Spratt, E A ^a   Gorcey, L V ^a   Soter, N A ^a   Brauer, J A ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LASER AND SKIN SURGERY CENTER OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY SURFACE; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; HUMAN; LUPUS ERYTHEMATOSUS; MORPHEA; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOTHERAPY; PRIORITY JOURNAL; PUVA; REVIEW; SCLERODERMA; SKIN BIOPSY; SKIN MANIFESTATION; CONNECTIVE TISSUE DISEASES; EPIDEMIOLOGY; PHOTOPHERESIS; PROCEDURES;

CONNECTIVE TISSUE DISEASES; EPIDEMIOLOGIC METHODS; HUMANS; PHOTOCHEMOTHERAPY; PHOTOPHERESIS; PHOTOTHERAPY;

EID: 84947035878     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13544     Document Type: Review

References (48)

1. Alster TS, Lupton JR,. Nonablative cutaneous remodeling using radiofrequency devices. Clin Dermatol 2007; 25: 487-91.
2. Gambichler T, Terras S, Kreuter A,. Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies. Clin Dermatol 2013; 31: 438-54.
3. Bulat V, Situm M, Dediol I, et al,. The mechanisms of action of phototherapy in the treatment of the most common dermatoses. Coll Antropol 2011; 35 (Suppl. 2): 147-51.
4. Chen J, Keltner L, Christophersen J, et al,. New technology for deep light distribution in tissue for phototherapy. Cancer J 2002; 8: 154-63.
5. Holbrook MR, Powell RJ,. Is there a future for extracorporeal photochemotherapy in the treatment of the rheumatological diseases? Ann Rheum Dis 1997; 56: 339-40.
6. Shekelle PG, Woolf SH, Eccles M, Grimshaw J,. Clinical guidelines: developing guidelines. BMJ 1999; 318: 593-6.
7. McGrath H Jr,. Ultraviolet Al (340-400 nm) irradiation and systemic lupus erythematosus. J Investig Dermatol Symp Proc 1999; 4: 79-84.
8. Cohen MR, Isenberg DA,. Ultraviolet irradiation in systemic lupus erythematosus: friend or foe? Br J Rheumatol 1996; 35: 1002-7.
9. Pavel S,. Light therapy (with UVA-1) for SLE patients: is it a good or bad idea? Rheumatology (Oxford) 2006; 45: 653-5.
10. Boeckler P, Liu V, Lipsker D,. Extracorporeal photopheresis in recalcitrant lupus erythematosus. Clin Exp Dermatol 2009; 34: e295-6.
11. Knobler RM, Graninger W, Lindmaier A, et al,. Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study. Arthritis Rheum 1992; 35: 319-24.
12. Zwischenberger BA, Jacobe HT,. A systematic review of morphea treatments and therapeutic algorithm. J Am Acad Dermatol 2011; 65: 925-41.
13. Fett N, Werth VP,. Update on morphea: part II. Outcome measures and treatment. J Am Acad Dermatol 2011; 64: 231-42.
14. Kreuter A, Hyun J, Stüucker M, et al,. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006; 54: 440-7.
15. Vasquez R, Jabbar A, Khan F, et al,. Recurrence of morphea after successful ultraviolet al phototherapy: a cohort study. J Am Acad Dermatol 2014; 70: 481-8.
16. Batchelor R, Lamb S, Goulden V, et al,. Photodynamic therapy for the treatment of morphoea. Clin Exp Dermatol 2008; 33: 661-3.
17. Karrer S, Abels C, Landthaler M, Szeimies RM,. Topical photodynamic therapy for localized scleroderma. Acta Derm Venereol 2000; 80: 26-7.
18. Knobler RM, French LE, Kim Y, et al,. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis. J Am Acad Dermatol 2006; 54: 793-9.
19. Enomoto DN, Mekkes JR, Bossuyt PM, et al,. Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis). J Am Acad Dermatol 1999; 41: 915-22.
20. De Wilde A, DiSpaltro FX, Geller A, et al,. Extracorporeal photochemotherapy as adjunctive treatment in juvenile dermatomyositis: a case report. Arch Dermatol 1992; 128: 1656-7.
21. Kim NN, Lio PA, Morgan GA, et al,. Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis. Arch Dermatol 2011; 147: 831-5.
22. Cheong WK, Hughes GR, Norris PG, Hawk JL,. Cutaneous photosensitivity in dermatomyositis. Br J Dermatol 1994; 131: 205-8.
23. Sinoway PA, Davidson CL, Callen JP,. Dermatomyositis occurring during psoralen A (PUVA) therapy. J Rheumatol 1994; 21: 353-6.
24. McGrath H Jr,. Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1994; 12: 129-35.
25. McGrath H, Martinez-Osuna P, Lee FA,. Ultraviolet-A1 (340-400 nm) irradiation therapy in systemic lupus erythematosus. Lupus 1996; 5: 269-74.
26. Polderman MC, Le Cessie S, Huizinga TW, Pavel S,. Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus. Rheumatology (Oxford) 2004; 43: 1402-4.
27. Polderman MC, Huizinga TW, Le Cessie S, Pavel S,. UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial. Ann Rheum Dis 2001; 60: 112-15.
28. Molina JF, McGrath H Jr,. Longterm ultraviolet-A1 irradiation therapy in systemic lupus erythematosus. J Rheumatol 1997; 24: 1072-4.
29. McGrath H Jr,. Elimination of anticardiolipin antibodies and cessation of cognitive decline in a UV-A1-irradiated systemic lupus erythematosus patient. Lupus 2005; 14: 859-61.
30. Romero-Maté A, Castaño-Suárez E, García-Donoso C, et al,. Unsuccessful treatment of recalcitrant cutaneous discoid lupus erythematosus with photodynamic therapy. Photodermatol Photoimmunol Photomed 2010; 26: 156-8.
31. Fernández-Guarino M, Pérez-García B, Harto A, Jaén P,. Discoid lupus erythematosus: good response to treatment with photodynamic therapy. J Eur Acad Dermatol Venereol 2008; 22: 1142-3.
32. Fai D, Romano I, Cassano N, Vena GA,. Cutaneous lupus erythematosus of the scalp treated with methyl-aminolevulinate photodynamic therapy: a case report. G Ital Dermatol Venereol 2012; 147: 213-15.
33. Motta S, Monti M,. Photodynamic therapy- A promising treatment option for autoimmune skin ulcers: a case report. Photochem Photobiol Sci 2007; 6: 1150-1.
34. Wollina U, Looks A,. Extracorporeal photochemotherapy in cutaneous lupus erythematosus. J Eur Acad Dermatol Venereol 1999; 13: 127-30.
35. Kerscher M, Meurer M, Sander C, et al,. PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients. Arch Dermatol 1996; 132: 1280-2.
36. Buense R, Duarte IA, Bouer M,. Localized scleroderma: assessment of the therapeutic response to phototherapy. An Bras Dermatol 2012; 87: 63-9.
37. Morita A, Kobayashi K, Isomura I, et al,. Ultraviolet al (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol 2000; 43: 670-4.
38. von Kobyletzki G, Uhle A, Pieck C, et al,. Acrosclerosis in patients with systemic sclerosis responds to low-dose UV-A1 phototherapy. Arch Dermatol 2000; 136: 275-6.
39. Luftl M, Degitz K, Plewig G, Rocken M,. Psoralen bath plus UV-A therapy. Possibilities and limitations. Arch Dermatol 1997; 133: 1597-603.
40. Pavlotsky F, Sakka N, Lozinski A, Barzilai A,. Bath psoralen-UVA photochemotherapy for localized scleroderma: experience from a single institute. Photodermatol Photoimmunol Photomed 2013; 29: 247-52.
41. Kanekura T, Fukumaru S, Matsushita S, et al,. Successful treatment of scleroderma with PUVA therapy. J Dermatol 1996; 23: 455-9.
42. Hofer A, Soyer HP,. Oral psoralen-UV-A for systemic scleroderma. Arch Dermatol 1999; 135: 603-4.
43. Papp G, Horvath IF, Barath S, et al,. Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis. Clin Immunol 2012; 142: 150-9.
44. Cribier B, Faradji T, Le Coz C, et al,. Extracorporeal photochemotherapy in systemic sclerosis and severe morphea. Dermatology 1995; 191: 25-31.
45. Krasagakis K, Dippel E, Ramaker J, et al,. Management of severe scleroderma with long-term extracorporeal photopheresis. Dermatology 1998; 196: 309-15.
46. Neustadter JH, Samarin F, Carlson KR, Girardi M,. Extracorporeal photochemotherapy for generalized deep morphea. Arch Dermatol 2009; 145: 127-30.
47. Schlaak M, Friedlein H, Kauer F, et al,. Successful therapy of a patient with therapy recalcitrant generalized bullous scleroderma by extracorporeal photopheresis and mycophenolate mofetil. J Eur Acad Dermatol Venereol 2008; 22: 631-3.
48. Pileri A, Raone B, Raboni R, et al,. Generalized morphea successfully treated with extracorporeal photochemotherapy (ECP). Dermatol Online J 2014; 20: 21258.